Latest Articles

Publication Date
Functional Impairment of Activated Regulatory T Cells as a Central Immunological Defect in Endometriosis.

Endometriosis is increasingly recognized as a disorder of impaired reproductive immune tolerance rather than solely an endocrine disease. Although previous studies have reported inconsistent findings regarding the number of regulatory …

Published: April 16, 2026, midnight
Nursing-led education and its impact on knowledge, self-care practices, and pain intensity in women with endometriosis.

Evaluate how a nursing-led education affects knowledge, self-care practices, and pain intensity in women with endometriosis.

Published: April 16, 2026, midnight
Medical and Surgical Management of Endometriosis: A Narrative Review of Clinical Outcomes.

Endometriosis is a chronic, estrogen-dependent, and heterogeneous gynecologic disorder associated with persistent pain, infertility, and substantial impairment in quality of life (QoL), necessitating individualized and evidence-based management. This narrative review …

Published: April 16, 2026, midnight
BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer - BioPharm International

BioNTech and DualityBio Report Clinically Meaningful Efficacy for Trastuzumab Pamirtecan in HER2-Expressing Endometrial Cancer BioPharm International

Published: April 15, 2026, 10:02 p.m.
Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target - TipRanks

Advancing ABS-201 in Underserved Hair Loss and Endometriosis Markets Supports Buy Rating and $9 Target TipRanks

Published: April 15, 2026, 9:42 p.m.
SimonMed collaborates with women's health AI company to improve MRI diagnoses - Radiology Business

SimonMed collaborates with women's health AI company to improve MRI diagnoses Radiology Business

Published: April 15, 2026, 9:27 p.m.
Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy - TipRanks

Medicus Pharma Showcases Long-Acting Teverelix Data, Targets Precision Endometriosis Therapy TipRanks

Published: April 15, 2026, 1:38 p.m.
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression - The Manila Times

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression The Manila Times

Published: April 15, 2026, 11:45 a.m.
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression - GlobeNewswire

Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression GlobeNewswire

Published: April 15, 2026, 11:30 a.m.
Endometriosis, a 'stumbling block' in the slow progress of women's health - Il Sole 24 ORE

Endometriosis, a 'stumbling block' in the slow progress of women's health Il Sole 24 ORE

Published: April 15, 2026, 10:48 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!